© 2020 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2020 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
August 14, 2007
A German study has found that FDG PET can differentiate between responders and nonresponders two weeks after the initiation of neoadjuvant chemotherapy for advanced adenocarcinoma of the esophagogastric junction.